# Phosphate Handling > Phosphate handling for MBBS Physiology: body distribution, proximal tubule NaPi transporters, PTH and FGF23 control, refeeding syndrome and CKD bone disease. - Canonical URL: https://prepelephant.com/topics/mbbs/physiology/phosphate-handling - Exam / course: MBBS · Subject: Physiology - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-02 - Last updated: 2026-10-02 - How to cite: "Phosphate Handling", PrepElephant, https://prepelephant.com/topics/mbbs/physiology/phosphate-handling ## Direct answer Bones bank about 85% of the body's phosphate, soft tissues hold most of the rest as the phosphate of ATP, phospholipids and nucleotides, and under 1% circulates in extracellular fluid at a concentration of 2.5-4.5 mg/dL — a fraction defended mainly by the proximal tubule, which reabsorbs 80-90% of the filtered load through sodium-phosphate cotransporters (NaPi-IIa and NaPi-IIc). Two phosphaturic hormones control that number: parathyroid hormone, which internalises the cotransporters within minutes, and fibroblast growth factor 23 from osteocytes, which requires its co-receptor Klotho and additionally suppresses renal 1-alpha-hydroxylase while lowering parathyroid hormone itself. Because phosphate rides cellular metabolism, clinical trouble comes from two directions: acute hypophosphataemia from the intracellular shift of refeeding (the crash of ATP and 2,3-DPG in malnourished and alcoholic patients), and chronic hyperphosphataemia in chronic kidney disease, where retained phosphate drives secondary hyperparathyroidism, vascular calcification and renal bone disease. ## What you must remember - **Distribution and normal range:** 85% bone, 14% intracellular organic phosphates, under 1% in extracellular fluid at 2.5-4.5 mg/dL; roughly a tenth is protein-bound, the remainder ultrafiltrable. - **Reabsorptive machinery:** proximal tubular NaPi-IIa/IIc cotransporters recover 80-90% of filtered phosphate; the transporters are the regulated step, not filtration. - **Parathyroid hormone action:** rapid (minutes) internalisation and degradation of NaPi transporters — phosphaturic, hypercalcaemic in net effect, and rises in phosphate retention. - **Fibroblast growth factor 23:** osteocyte-derived hormone acting through FGFR1 plus Klotho; phosphaturic, suppresses 1,25-dihydroxy vitamin D synthesis (unlike PTH which raises it) and directly lowers PTH — the three differences examiners ask for. - **Hypophosphataemia settings:** refeeding syndrome (insulin-driven cellular uptake after starvation or alcohol misuse), respiratory alkalosis (intracellular shift), diabetic ketoacidosis recovery, osmotic diuresis and antacid binding — weakness, rhabdomyolysis, respiratory muscle failure and haemolysis at levels under about 1 mg/dL. - **Hyperphosphataemia settings:** chronic kidney disease above stage 3-4, tumour lysis, rhabdomyolysis and hypoparathyroidism; the chronic kidney disease-mineral bone disorder sequence of retained phosphate, falling calcitriol, rising PTH and vascular calcification. - **Inherited anchors:** X-linked hypophosphataemic rickets (PHEX mutation, FGF23 excess, low phosphate with calcium normal) and tumour-induced osteomalacia — the physiology of FGF23 excess made clinical. ## A refeeding scenario, walked stepwise A severely malnourished adolescent admitted with anorexia nervosa is started on feeds and on day three develops diplopia, respiratory weakness and phosphate at 0.9 mg/dL with potassium 2.9 mEq/L and magnesium 1.3 mg/dL. Sequence the physiology: insulin rises with carbohydrate, driving glucose, phosphate, potassium and magnesium into cells for ATP synthesis and glycogen storage (each gram of glycogen sequesters phosphate); thiamine-dependent pathways accelerate; the suddenly anabolic liver and muscle drain a circulation already running on empty. The prevention is the treatment: start feeds at 5-10 kcal per kg per day in the highest-risk patients, give thiamine before the first feed, and monitor phosphate, potassium, magnesium daily for the first week — the standard refeeding precaution that NICE guidance formalised and Indian hospital protocols increasingly mirror. Now the mirror image in a dialysis-stage patient: phosphate 6.8 mg/dL with raised PTH and pruritus; dietary phosphate restriction, calcium or non-calcium binders with meals, and adjusted dialysis all target the same cotransporter logic from the retention end. ## Where students slip The PTH-FGF23 comparison is where marks are lost: both are phosphaturic, but PTH stimulates 1-alpha-hydroxylase while FGF23 suppresses it, and FGF23 lowers PTH while phosphate retention raises it — draw the loop in words before answering. Second, students call vitamin D simply a "phosphate-raising vitamin": correct in net terms (intestinal absorption of both ions), but in chronic kidney disease the failing 1-alpha-hydroxylase and rising FGF23 both collapse calcitriol, so the phosphate rises before the calcium falls. Third, refeeding hypophosphataemia is misattributed to "dilution"; it is an intracellular uptake event, which is precisely why it can kill through ATP failure rather than through concentration alone. Finally, do not forget respiratory alkalosis as a cause — transcellular shift, not loss — a favourite one-line answer in university papers. ## Frequently asked questions ### How much filtered phosphate does the proximal tubule reabsorb? About 80-90%, via sodium-dependent NaPi-IIa and NaPi-IIc cotransporters, whose internalisation by PTH and FGF23 produces phosphaturia. ### How does FGF23 differ from PTH in phosphate-vitamin D control? Both are phosphaturic, but FGF23 (acting with Klotho) suppresses 1-alpha-hydroxylase and lowers PTH, whereas PTH stimulates the enzyme — so FGF23 lowers 1,25-dihydroxy vitamin D while PTH raises it. ### Why does refeeding starved patients cause hypophosphataemia? Insulin drives phosphate into cells for ATP and glycogen synthesis, depleting an already marginal extracellular pool within 24-72 hours of feeding. ### What is the chronic kidney disease-mineral bone disorder sequence? Retained phosphate and falling calcitriol raise PTH chronically, producing bone resorption, brown tumours and extra-skeletal calcification alongside rising FGF23. ### Which inherited disorder causes FGF23-mediated phosphate wasting? X-linked hypophosphataemic rickets from PHEX mutations — rickets with low serum phosphate, normal calcium and urinary phosphate wasting.